 | • レポートコード：GIR201102193 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、セレコキシブの世界市場を調査対象にし、セレコキシブの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（50mg、100mg、200mg、400mg）、用途別分析（関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer Inc、Apotex、Teva、Mylan、Hengrui Medicine、Lupin ・メーカー別販売量、売上、市場シェア ・セレコキシブの地域別市場分析 ・セレコキシブの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・セレコキシブのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・セレコキシブのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・セレコキシブの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・セレコキシブの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・セレコキシブの種類別市場規模2015-2020：50mg、100mg、200mg、400mg ・セレコキシブの用途別市場規模2015-2020：関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他 ・セレコキシブの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Celecoxib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Celecoxib market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 1588.9 million by 2025, from USD 1167.9 million in 2019.
Market segmentation
Celecoxib market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Celecoxib market has been segmented into
50mg
100mg
200mg
400mg
By Application, Celecoxib has been segmented into:
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Celecoxib market presented in the report. This section sheds light on the sales growth of different regional and country-level Celecoxib markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Celecoxib market.
The report offers in-depth assessment of the growth and other aspects of the Celecoxib market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Celecoxib Market Share Analysis
Celecoxib competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Celecoxib sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Celecoxib sales, revenue and market share for each player covered in this report.
The major players covered in Celecoxib are:
Pfizer Inc
Apotex
Teva
Mylan
Hengrui Medicine
Lupin
Among other players domestic and global, Celecoxib market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Celecoxib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Celecoxib, with price, sales, revenue and global market share of Celecoxib in 2018 and 2019.
Chapter 3, the Celecoxib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celecoxib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Celecoxib market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Celecoxib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Celecoxib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Celecoxib Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Celecoxib Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Overview of Global Celecoxib Market
1.4.1 Global Celecoxib Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc SWOT Analysis
2.1.4 Pfizer Inc Product and Services
2.1.5 Pfizer Inc Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business
2.2.3 Apotex SWOT Analysis
2.2.4 Apotex Product and Services
2.2.5 Apotex Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva SWOT Analysis
2.3.4 Teva Product and Services
2.3.5 Teva Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan SWOT Analysis
2.4.4 Mylan Product and Services
2.4.5 Mylan Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hengrui Medicine
2.5.1 Hengrui Medicine Details
2.5.2 Hengrui Medicine Major Business
2.5.3 Hengrui Medicine SWOT Analysis
2.5.4 Hengrui Medicine Product and Services
2.5.5 Hengrui Medicine Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Product and Services
2.6.4 Lupin Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Celecoxib Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Celecoxib Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Celecoxib Manufacturer Market Share in 2019
3.3.2 Top 6 Celecoxib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Celecoxib Sales, Revenue and Market Share by Regions
4.1.1 Global Celecoxib Sales and Market Share by Regions (2015-2020)
4.1.2 Global Celecoxib Revenue and Market Share by Regions (2015-2020)
4.2 North America Celecoxib Sales and Growth Rate (2015-2020)
4.3 Europe Celecoxib Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Celecoxib Sales and Growth Rate (2015-2020)
4.5 South America Celecoxib Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Celecoxib Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Celecoxib Sales, Revenue and Market Share by Country
5.1.1 North America Celecoxib Sales and Market Share by Country (2015-2020)
5.1.2 North America Celecoxib Revenue and Market Share by Country (2015-2020)
5.2 United States Celecoxib Sales and Growth Rate (2015-2020)
5.3 Canada Celecoxib Sales and Growth Rate (2015-2020)
5.4 Mexico Celecoxib Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Celecoxib Sales, Revenue and Market Share by Country
6.1.1 Europe Celecoxib Sales and Market Share by Country (2015-2020)
6.1.2 Europe Celecoxib Revenue and Market Share by Country (2015-2020)
6.2 Germany Celecoxib Sales and Growth Rate (2015-2020)
6.3 UK Celecoxib Sales and Growth Rate (2015-2020)
6.4 France Celecoxib Sales and Growth Rate (2015-2020)
6.5 Russia Celecoxib Sales and Growth Rate (2015-2020)
6.6 Italy Celecoxib Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Celecoxib Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Celecoxib Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Celecoxib Revenue and Market Share by Regions (2015-2020)
7.2 China Celecoxib Sales and Growth Rate (2015-2020)
7.3 Japan Celecoxib Sales and Growth Rate (2015-2020)
7.4 Korea Celecoxib Sales and Growth Rate (2015-2020)
7.5 India Celecoxib Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Celecoxib Sales and Growth Rate (2015-2020)
7.7 Australia Celecoxib Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Celecoxib Sales, Revenue and Market Share by Country
8.1.1 South America Celecoxib Sales and Market Share by Country (2015-2020)
8.1.2 South America Celecoxib Revenue and Market Share by Country (2015-2020)
8.2 Brazil Celecoxib Sales and Growth Rate (2015-2020)
8.3 Argentina Celecoxib Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Celecoxib Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Celecoxib Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Celecoxib Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Celecoxib Sales and Growth Rate (2015-2020)
9.3 Turkey Celecoxib Sales and Growth Rate (2015-2020)
9.4 Egypt Celecoxib Sales and Growth Rate (2015-2020)
9.5 South Africa Celecoxib Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Celecoxib Sales and Market Share by Type (2015-2020)
10.2 Global Celecoxib Revenue and Market Share by Type (2015-2020)
10.3 Global Celecoxib Price by Type (2015-2020)
11 Global Celecoxib Market Segment by Application
11.1 Global Celecoxib Sales Market Share by Application (2015-2020)
11.2 Global Celecoxib Revenue Market Share by Application (2015-2020)
11.3 Global Celecoxib Price by Application (2015-2020)
12 Market Forecast
12.1 Global Celecoxib Sales, Revenue and Growth Rate (2021-2025)
12.2 Celecoxib Market Forecast by Regions (2021-2025)
12.2.1 North America Celecoxib Market Forecast (2021-2025)
12.2.2 Europe Celecoxib Market Forecast (2021-2025)
12.2.3 Asia-Pacific Celecoxib Market Forecast (2021-2025)
12.2.4 South America Celecoxib Market Forecast (2021-2025)
12.2.5 Middle East & Africa Celecoxib Market Forecast (2021-2025)
12.3 Celecoxib Market Forecast by Type (2021-2025)
12.3.1 Global Celecoxib Sales Forecast by Type (2021-2025)
12.3.2 Global Celecoxib Market Share Forecast by Type (2021-2025)
12.4 Celecoxib Market Forecast by Application (2021-2025)
12.4.1 Global Celecoxib Sales Forecast by Application (2021-2025)
12.4.2 Global Celecoxib Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Celecoxib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Celecoxib by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Celecoxib Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Celecoxib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Inc Celecoxib Major Business
Table 10. Pfizer Inc Celecoxib Total Revenue (USD Million) (2018-2019)
Table 11. Pfizer Inc SWOT Analysis
Table 12. Pfizer Inc Celecoxib Product and Services
Table 13. Pfizer Inc Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Apotex Basic Information, Manufacturing Base and Competitors
Table 15. Apotex Celecoxib Major Business
Table 16. Apotex Celecoxib Total Revenue (USD Million) (2018-2019)
Table 17. Apotex SWOT Analysis
Table 18. Apotex Celecoxib Product and Services
Table 19. Apotex Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Teva Basic Information, Manufacturing Base and Competitors
Table 21. Teva Celecoxib Major Business
Table 22. Teva Celecoxib Total Revenue (USD Million) (2018-2019)
Table 23. Teva SWOT Analysis
Table 24. Teva Celecoxib Product and Services
Table 25. Teva Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Mylan Basic Information, Manufacturing Base and Competitors
Table 27. Mylan Celecoxib Major Business
Table 28. Mylan Celecoxib Total Revenue (USD Million) (2018-2019)
Table 29. Mylan SWOT Analysis
Table 30. Mylan Celecoxib Product and Services
Table 31. Mylan Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 33. Hengrui Medicine Celecoxib Major Business
Table 34. Hengrui Medicine Celecoxib Total Revenue (USD Million) (2018-2019)
Table 35. Hengrui Medicine SWOT Analysis
Table 36. Hengrui Medicine Celecoxib Product and Services
Table 37. Hengrui Medicine Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Lupin Basic Information, Manufacturing Base and Competitors
Table 39. Lupin Celecoxib Major Business
Table 40. Lupin Celecoxib Total Revenue (USD Million) (2018-2019)
Table 41. Lupin SWOT Analysis
Table 42. Lupin Celecoxib Product and Services
Table 43. Lupin Celecoxib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Global Celecoxib Sales by Manufacturer (2018-2019) (K Units)
Table 45. Global Celecoxib Revenue by Manufacturer (2018-2019) (USD Million)
Table 46. Global Celecoxib Sales by Regions (2015-2020) (K Units)
Table 47. Global Celecoxib Sales Market Share by Regions (2015-2020)
Table 48. Global Celecoxib Revenue by Regions (2015-2020) (USD Million)
Table 49. North America Celecoxib Sales by Countries (2015-2020) (K Units)
Table 50. North America Celecoxib Sales Market Share by Countries (2015-2020)
Table 51. North America Celecoxib Revenue by Countries (2015-2020) (USD Million)
Table 52. North America Celecoxib Revenue Market Share by Countries (2015-2020)
Table 53. Europe Celecoxib Sales by Countries (2015-2020) (K Units)
Table 54. Europe Celecoxib Sales Market Share by Countries (2015-2020)
Table 55. Europe Celecoxib Revenue by Countries (2015-2020) (USD Million)
Table 56. Asia-Pacific Celecoxib Sales by Regions (2015-2020) (K Units)
Table 57. Asia-Pacific Celecoxib Sales Market Share by Regions (2015-2020)
Table 58. Asia-Pacific Celecoxib Revenue by Regions (2015-2020) (USD Million)
Table 59. South America Celecoxib Sales by Countries (2015-2020) (K Units)
Table 60. South America Celecoxib Sales Market Share by Countries (2015-2020)
Table 61. South America Celecoxib Revenue by Countries (2015-2020) (USD Million)
Table 62. South America Celecoxib Revenue Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Celecoxib Sales by Countries (2015-2020) (K Units)
Table 64. Middle East & Africa Celecoxib Sales Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Celecoxib Revenue by Countries (2015-2020) (USD Million)
Table 66. Middle East & Africa Celecoxib Revenue Market Share by Countries (2015-2020)
Table 67. Global Celecoxib Sales by Type (2015-2020) (K Units)
Table 68. Global Celecoxib Sales Share by Type (2015-2020)
Table 69. Global Celecoxib Revenue by Type (2015-2020) (USD Million)
Table 70. Global Celecoxib Revenue Share by Type (2015-2020)
Table 71. Global Celecoxib Sales by Application (2015-2020) (K Units)
Table 72. Global Celecoxib Sales Share by Application (2015-2020)
Table 73. Global Celecoxib Sales Forecast by Regions (2021-2025) (K Units)
Table 74. Global Celecoxib Market Share Forecast by Regions (2021-2025)
Table 75. Global Celecoxib Sales Forecast by Type (2021-2025) (K Units)
Table 76. Global Celecoxib Market Share Forecast by Type (2021-2025)
Table 77. Global Celecoxib Sales Forecast by Application (2021-2025)
Table 78. Global Celecoxib Market Share Forecast by Application (2021-2025)
Table 79. Direct Channel Pros & Cons
Table 80. Indirect Channel Pros & Cons
Table 81. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Celecoxib Picture
Figure 2. Global Sales Market Share of Celecoxib by Type in 2019
Figure 3. 50mg Picture
Figure 4. 100mg Picture
Figure 5. 200mg Picture
Figure 6. 400mg Picture
Figure 7. Celecoxib Sales Market Share by Application in 2019
Figure 8. Rheumatoid arthritis Picture
Figure 9. osteoarthritis Picture
Figure 10. Acute pain Picture
Figure 11. Musculoskeletal pain Picture
Figure 12. Other diseases Picture
Figure 13. Global Celecoxib Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Celecoxib Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Celecoxib Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Celecoxib Sales Market Share by Manufacturer in 2019
Figure 34. Global Celecoxib Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Celecoxib Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Celecoxib Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Celecoxib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Celecoxib Revenue Market Share by Regions (2015-2020)
Figure 41. Global Celecoxib Revenue Market Share by Regions in 2018
Figure 42. North America Celecoxib Sales and Growth Rate (2015-2020)
Figure 43. Europe Celecoxib Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Celecoxib Sales and Growth Rate (2015-2020)
Figure 45. South America Celecoxib Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Celecoxib Sales and Growth Rate (2015-2020)
Figure 47. North America Celecoxib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Celecoxib Sales Market Share by Countries (2015-2020)
Figure 49. North America Celecoxib Sales Market Share by Countries in 2018
Figure 50. North America Celecoxib Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Celecoxib Revenue Market Share by Countries in 2018
Figure 52. United States Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Celecoxib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Celecoxib Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Celecoxib Revenue Market Share by Countries in 2019
Figure 58. Germany Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Celecoxib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Celecoxib Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Celecoxib Revenue Market Share by Regions 2019
Figure 66. China Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Celecoxib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Celecoxib Sales Market Share by Countries in 2019
Figure 73. South America Celecoxib Revenue Market Share by Countries in 2019
Figure 74. Brazil Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Celecoxib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Celecoxib Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Celecoxib Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Celecoxib Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Celecoxib Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Celecoxib Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Celecoxib Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Celecoxib Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Celecoxib Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Celecoxib Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Celecoxib Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Celecoxib Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
セレコキシブカプセルの世界市場 2020年 Market Overview The Celecoxib Capsule market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 変形性関節症鎮痛剤の世界市場 2020年 Market Overview The Osteoarthritis Pain Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 変形性関節症苦痛治療薬の世界市場 2020年 Market Overview The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 変形性関節症疼痛の世界市場 2020年 Market Overview The global Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis Pain marke…
- 関節リウマチ（RA）・ループス治療の世界市場 2020年 Market Overview The global Rheumatoid Arthritis and Lupus Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rhe…